Literature DB >> 25100150

Static and dynamic prognostic factors of papillary thyroid carcinoma.

Yasuhiro Ito1, Akira Miyauchi, Kaoru Kobayashi, Minoru Kihara, Akihiro Miya.   

Abstract

The two types of prognostic factors of papillary thyroid carcinoma (PTC) are static and dynamic. The following static prognostic factors have been conventionally adopted: age, tumor size, extrathyroid extension, lymph node metastasis, and distant metastasis based on pre-, intra- and post-operative findings. These factors are useful to decide therapeutic strategies for PTC patients, including the extent of surgery and radioactive iodine (RAI) ablation. However, even the combination of these factors evaluated pathologically postoperatively is not good enough at predicting recurrence in clinical settings. The dynamic prognostic factors of changes in serum thyroglobulin (Tg) and thyroglobulin antibody (TgAb) values in patients who have undergone a total thyroidectomy are important to evaluate the progression of carcinoma recurrence and to predict patients' cause-specific survival, regardless of their backgrounds and the clinicopathological features of their PTC. Dynamic prognostic factors are superior to static prognostic factors in terms of expressing the condition of recurrence on a real-time basis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25100150     DOI: 10.1507/endocrj.EJ14-0303

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  9 in total

1.  The features of contrast enhanced ultrasound and BRAF V600E in papillary thyroid carcinoma.

Authors:  Zi-Mei Lin; Cao-Xin Yan; Yue Song; Yu-Rong Hong; Qing Wen; Yong-Yuan Xu; Min-Qiang Pan; Qin Ye; Pin-Tong Huang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.

Authors:  Woon Won Kim; Tae Kwun Ha; Sung Kwon Bae
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-01-09

3.  Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer.

Authors:  Tomasz Stępień; Mateusz Brożyna; Krzysztof Kuzdak; Ewelina Motylewska; Jan Komorowski; Henryk Stępień; Hanna Ławnicka
Journal:  Dis Markers       Date:  2017-01-31       Impact factor: 3.434

4.  A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1.

Authors:  Keisuke Enomoto; Fuyuki Sato; Shunji Tamagawa; Mehmet Gunduz; Naoyoshi Onoda; Shinya Uchino; Yasuteru Muragaki; Muneki Hotomi
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

5.  Relationship between the upregulation of Notch1 signaling and the clinical characteristics of patients with papillary thyroid carcinoma in East Asia: a systematic review and meta-analysis.

Authors:  Libing Yuan; Lei Ma; Haibo Xue; Shoujun Song
Journal:  Cancer Cell Int       Date:  2019-01-03       Impact factor: 5.722

6.  Prediction of the Prognosis Based on Chromosomal Instability-Related DNA Methylation Patterns of ELOVL2 and UBAC2 in PTCs.

Authors:  Jun Han; Meijun Chen; Qingxiao Fang; Yanqing Zhang; Yihan Wang; Jamaspishvili Esma; Hong Qiao
Journal:  Mol Ther Nucleic Acids       Date:  2019-10-07       Impact factor: 8.886

7.  Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer.

Authors:  David Kersting; Walter Jentzen; Miriam Sraieb; Pedro Fragoso Costa; Maurizio Conti; Lale Umutlu; Gerald Antoch; Michael Nader; Ken Herrmann; Wolfgang Peter Fendler; Christoph Rischpler; Manuel Weber
Journal:  EJNMMI Phys       Date:  2021-02-15

8.  Depletion of VAX2 Restrains the Malignant Progression of Papillary Thyroid Carcinoma by Modulating ERK Signaling Pathway.

Authors:  Bei Guo; Yi Zhang; Kun Yuan; Feng-Xia Jiang; Qian-Bo Cui; Qin Zhou; Hong-Xia Dong; Wei Chen; Shun-Shi Yang
Journal:  Open Life Sci       Date:  2019-07-10       Impact factor: 0.938

9.  Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma.

Authors:  Ching-Ping Tseng; Kong-Kit Leong; Miaw-Jene Liou; Hsueh-Ling Hsu; Hung-Chih Lin; Yi-An Chen; Jen-Der Lin
Journal:  Oncotarget       Date:  2017-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.